Gryphon Scientific

Gryphon Scientific is a U.S.-based scientific research and consulting company focused on public health, biosafety, biosecurity, emergency preparedness, and related life science policy and analytics. The company has provided scientific analysis, modeling, risk assessment, literature review, and decision-support services to government and commercial clients, rather than developing its own therapeutic drug pipeline. Gryphon has also conducted health research activities, including multiple sclerosis study support and broader epidemiology and health services work. In April 2024, Deloitte announced that it had acquired substantially all of the assets of Gryphon Scientific, with Gryphon’s team and capabilities being integrated to expand Deloitte’s security, science, and public health offerings.